Clinical trials: Thrombophlebitis
Thrombophlebitis
POST (Prospective Observational Superfial Thrombophlebitis)
We performed a national cross-sectional and prospective large epidemiological cohort study in patients with ST. Office- and hospital-based vascular medicine French practitioners enrolled all consecutive patients with a…
- Trial name
- POST (NCT00818688)
- Testing
- compression ultrasonography at 3 months
- Where
- 5 sites in France
- Volunteers
- 844 people
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
Septic Thrombophlebitis
Description of Septic Thrombophlebitis on Central Venous Catheter and Midline
Central venous catheters improve the tolerability and feasibility of patient care in the hospital setting by allowing the administration of hyper-osmotic, vesicant and venotoxic fluids.
- Trial name
- THROMBOSEP (NCT05743738)
- Testing
- Doppler ultrasound
- Where
- 2 sites in France
- Volunteers
- 120 people
- Sponsor
- Centre Hospitalier le Mans
Superficial Thrombophlebitis of the Upper Limb
Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins
This study will assess the efficacy, safety and tolerability of topically administered diclofenac gel versus placebo with respect to the symptom score (pain, temperature and size of erythema along the superficial vein)
- Trial name
- NCT00377806
- Testing
- Diclofenac gel
- Where
- Germany
- Volunteers
- 200 people
- Sponsor
- Novartis
Deep Venous Thrombosis
Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities
The purpose of the study was to evaluate efficacy and safety of the new acute treatment of deep venous thrombosis by use of low-molecular-weight heparin compared with standard treatment using unfractionated heparin, especially…
- Trial name
- NCT00628576
- Testing
- unfractionated heparin, Tinzaparin (Leo)
- Where
- Denmark
- Volunteers
- 99 people
- Sponsor
- Aalborg University Hospital
Venous Thromboembolic Disease
Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin
Elderly subjects are at greater risk of thrombophlebitis than the general population, but also of bleeding when anticoagulant therapy is initiated.
- Trial name
- ENOX-VTD-H (NCT05150314)
- Where
- France
- Volunteers
- 2,000 people
- Sponsor
- University Hospital, Strasbourg, France
Chronic Venous Insufficiency, Varicose Vein
Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins
Evaluation efficacy and safety of Esarin Gel in subjects with chronic venous insufficiency or varicose veins combine superficial vein thrombophlebitis.
- Conditions
- Chronic Venous Insufficiency, Varicose Vein, Superficial Vein Thrombophlebitis
- Trial name
- NCT02346058
- Testing
- Esarin Gel
- Where
- Taiwan
- Volunteers
- 53 people
- Sponsor
- Ten Sun Pharma Company Limited
Thrombophlebitis, Phlebitis
Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis
Patients receiving nutritional emulsion for at least 3 days will be treated with Hirudoid cream or placebo cream to prevent and treat phlebitis caused by the infusion.
- Trial name
- NCT01943006
- Testing
- Hirudoid cream 0.3 % Mucopolysaccharide polysulfate
- Where
- 4 sites in Thailand
- Volunteers
- 144 people
- Sponsor
- Medinova AG